X2 Biosystems is looking to bring in $5 million in a new funding round.
The Seattle-based medical device company is offering debt and options in this round. The company has yet to attract investors, according to a regulatory filing.
X2 was founded by former Roche (PINK:RHHBY) and Abbott (NYSE:ABT) marketing executive Rich Able and mechanical engineer Christoph Mack. Their main product is the xPatch, a wearable concussion detection sensor, about the size of a postage stamp and designed to be worn behind the ear, that sends impact metrics to a web-based database, according to the company’s website.
The company had a funding round in July, where it was seeking $12.5 million. The company brought in 18 unnamed investors, to the tune of $3.3 million, according to regulatory filings.